Hemoalgae Overview

  • Founded
  • 2016
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Hemoalgae General Information

Description

Developer of a bio based technological platform designed to develop high valuable proteins and compounds through genetic engineering tools. The company's platform uses microalgae for the production of proteins and other compounds which are hard to find from natural sources such as their first product, hirudin which can be found in leeches and acts as a thrombin inhibitor, enabling companies to avail hirudin and other valuable compounds in a more-efficient, sustainable and cost-effective way.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Primary Office
  • Cartago
  • Costa Rica
+506 8433 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hemoalgae Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 22-Mar-2021 00000 Completed Out of Business
2. Early Stage VC 04-Dec-2018 Cancelled Generating Revenue
1. Accelerator/Incubator 01-Oct-2016 $100K $100K 00.000 Completed Startup
To view Hemoalgae’s complete valuation and funding history, request access »